Sign in

Trial result ·

Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia.

Written based on 1 research study on PubMed, searched on 3 Nov 2026.

What was studied

This trial looked at food rules for people during cancer care. It included people having a stem cell transplant. It also included people starting strong chemo for acute leukemia. These people usually eat a strict diet that is low in germs. The trial tested a freer diet with fresh fruit and vegetables. People were put by chance into one of the diet groups.

What they found

The trial was stopped early, once 214 people could be counted. Serious infections were more common in the freer diet group. This went past a safety limit set before the trial began. People on the freer diet did not take in more calories. In both groups, a large share of people had serious food problems. The freer diet gave no gain in symptoms, quality of life or survival.

What it means for patients

The authors say their findings suggest the freer diet is not a safe choice. Their findings point to more infections with the freer diet. They also saw no gain in food intake or other areas. The authors say new diet plans are still needed. Such plans would aim to help people eat well and stay safe.

Why it is not certain yet

The trial ended early, at its second planned look at the data. The range of likely values for the infection gap was wide. That range also included no gap at all. The abstract does not give how long people were followed. It also does not say what caused the food problems in both groups.

The registered trial

The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.

Source

Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia.

PubMed · PMID 41406403

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Acute myeloid leukaemia publications